A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia
International Journal of Stem Cells · 30.08.2025 · 18 (3) · 254-262
DOI: 10.15283/ijsc25002 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Stem Cells, online erschienen am 17.03.2025. Verfasst von Yong-Man Park und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: S.Biomedics Co. Ltd., Seoul, South Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- S.Biomedics Co., Ltd., Seoul, Korea.
ORCID-Profile: Yong-Man Park, Joon-Kee Park, Hyo-Shin Kim, Shin-Seok Yang, Jong-Wan Kim, Dong-Ik Kim
Förderung
- S.Biomedics Co. Ltd., Seoul, South Korea
Zitieren
APA
Park, Y. M., Park, J. K., Kim, H. S., Yang, S. S., Kim, J. W., & Kim, D. I. (2025). A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia. International Journal of Stem Cells, 18(3), 254-262. https://doi.org/10.15283/ijsc25002
Vancouver
Park YM, Park JK, Kim HS, Yang SS, Kim JW, Kim DI. A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia. International Journal of Stem Cells. 2025;18(3):254-262. doi:10.15283/ijsc25002
BibTeX
@article{Park2025,
author = {Park, Yong-Man and Park, Joon-Kee and Kim, Hyo-Shin and Yang, Shin-Seok and Kim, Jong-Wan and Kim, Dong-Ik},
title = {A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia},
journal = {International Journal of Stem Cells},
year = {2025},
volume = {18},
number = {3},
pages = {254--262},
doi = {10.15283/ijsc25002}
}
EUVIMED